SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
zhanghaotol
Lv5
1380 积分
2022-08-03 加入
最近求助
最近应助
互助留言
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: An open-label, randomized, multicenter, phase Ⅲ trial
1个月前
已关闭
Pointbreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small cell lung cancer
1个月前
已关闭
Abraxane®, a novel Cremophor® -free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
1个月前
已完结
Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer
1个月前
已关闭
Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small cell lung cancer: final results of a phase III trial
1个月前
已关闭
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
1个月前
已完结
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
1个月前
已完结
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer
1个月前
已完结
Phase III trial of nanoparticle albumin bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
1个月前
已关闭
中国阑尾肿瘤多学科综合治疗专家共识
1个月前
已完结
没有进行任何应助
已找到【积分已退回】
1个月前
速度真快
1个月前
已找到【积分已退回】
1个月前
https://doi.org/10.1200/JCO.2011.39.5848
1个月前
已找到【积分已退回】
1个月前
速度真快
1个月前
感谢
4个月前
感谢
4个月前
点赞
4个月前
速度真快
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论